MICHAEL HILBURN: Open Payments
NPI 1154082840 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 7 payments from 5 companies in 2025. Trend: 2023 $356 · 2024 $607 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| PFIZER INC. | 2 | $40 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| Novo Nordisk Inc | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: LEQVIO, VYNDAQEL, OPSUMIT, Wegovy, ELIQUIS.
Industry payments across AZ — which companies pay providers there.
